Oviva Therapeutics is a movement to improve women's experience of aging through biomedical research, development and advocacy.
Oviva Therapeutics has raised $11.5M in total funding. The most recent round was Seed. The last funding was announced in May 2022.
Oviva Therapeutics's investors include Cambrian Biopharma.
Oviva Therapeutics is headquartered in New York, United States.
Oviva Therapeutics is a movement to improve women's experience of aging through biomedical research, development and advocacy.
Oviva Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oviva Therapeutics — Funding & Investors." VCBacked, May 19, 2022, https://www.vcbacked.co/company/oviva-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). Oviva Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/oviva-therapeutics
{{cite web |title=Oviva Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/oviva-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated